Search

Your search keyword '"Xavier, Ricardo Machado"' showing total 570 results

Search Constraints

Start Over You searched for: Author "Xavier, Ricardo Machado" Remove constraint Author: "Xavier, Ricardo Machado"
570 results on '"Xavier, Ricardo Machado"'

Search Results

1. Effects of Participating in a Research Project During the COVID-19 Pandemic on Medical Students’ Educational Routines and Mental Health: Protocol for a Web-Based Survey Study

2. A Brazilian Cohort of Patients With Immuno-Mediated Chronic Inflammatory Diseases Infected by SARS-CoV-2 (ReumaCoV-Brasil Registry): Protocol for a Prospective, Observational Study

4. Safety of CoronaVac and ChAdOx1 vaccines against SARS-CoV-2 in patients with rheumatoid arthritis: data from the Brazilian multicentric study safer

9. Brazilian society of rheumatology methodological guide for the development of evidence-based clinical guidelines in rheumatology

11. Impact of Risk Factors on COVID‐19 Outcomes in Unvaccinated People With Rheumatic Diseases: A Comparative Analysis of Pandemic Epochs Using the COVID‐19 Global Rheumatology Alliance Registry

12. Muscle fibre morphometric analysis (MusMA) correlates with muscle function and cardiovascular risk prognosis

13. Physical frailty in patients with systemic sclerosis

16. Fasciola hepatica extract suppresses fibroblast-like synoviocytes in vitro and alleviates experimental arthritis

17. Guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: a Brazilian Society of Rheumatology task force

18. COVID-19 Impact on Patients with Immune-Mediated Rheumatic Disease: A Comparative Study of Disease Activity and Psychological Well-Being Over Six Months

19. CCR5 promoter region polymorphisms in systemic lupus erythematosus

20. Factors Associated With Mortality in Patients With Immune-Mediated Rheumatic Diseases and COVID-19 From Latin America

21. Safety of Coronavac and ChAdOx1 Vaccines Against SARS-CoV-2 in Patients with Rheumatoid Arthritis Data from the Brazilian Multicentric Study Safer

22. Recommendations of the Brazilian Society of Rheumatology for the use of JAK inhibitors in the management of rheumatoid arthritis

23. Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil

25. CCR5 promoter region polymorphisms in systemic lupus erythematosus.

26. Impact of Risk Factors on COVID‐19 Outcomes in Unvaccinated People with Rheumatic Diseases

27. HLA-B27 did not protect against COVID-19 in patients with axial Spondyloarthritis – Data from the ReumaCov-Brasil Registry

28. Assessment of muscle mass using chest computed tomography-based quantitative and qualitative measurements in patients with systemic sclerosis: A retrospective study with cross-sectional and longitudinal analyses

32. Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases

35. Burden of rheumatoid arthritis on patients’ work productivity and quality of life

36. Sarcopenia in Immune-Mediated Rheumatic Diseases-Review.

38. Changes in physical function over time in rheumatoid arthritis patients: A cohort study

39. TRANSCRANIAL DIRECT CURRENT STIMULATION DECREASES CHRONIC PAIN IN PATIENTS WITH RHEUMATOID ARTHRITIS: A RANDOMIZED, CONTROLLED, DOUBLE-BLIND CLINICAL TRIALTRANSCRANIAL DIRECT CURRENT STIMULATION DECREASES CHRONIC PAIN IN PATIENTS WITH RHEUMATOID ARTHRITIS: A RANDOMIZED, CONTROLLED, DOUBLE-BLIND CLINICAL TRIAL

41. INTERCHANGEABILITY AND CONTROVERSIES IN THE BIOSIMILARS USE: BRAZILIAN RHEUMATOLOGISTS AND GASTROENTEROLOGISTS OPINION

42. The II Brazilian Guidelines for the pharmacological treatment of patients hospitalized with COVID-19 Joint Guidelines of the Associação Brasileira de Medicina de Emergência, Associação de Medicina Intensiva Brasileira, Associação Médica Brasileira, Sociedade Brasileira de Angiologia e Cirurgia Vascular, Sociedade Brasileira de Infectologia, Sociedade Brasileira de Pneumologia e Tisiologia and Sociedade Brasileira de Reumatologia

44. ACTIVIN A AS A PREDICTOR OF MORTALITY IN SYSTEMIC SCLEROSIS

45. NEUROINFLAMMATION IN AN EXPERIMENTAL MODEL OF ARTHRITIS: A PILOT STUDY

46. DISEASE ACTIVITY OR LONG COVID-19 MANIFESTATIONS? DATA FROM THE REUMACOV BRASIL COHORT

47. II Diretrizes Brasileiras para o tratamento farmacológico de pacientes hospitalizados com COVID-19 Diretriz conjunta da Associação Brasileira de Medicina de Emergência, Associação de Medicina Intensiva Brasileira, Associação Médica Brasileira, Sociedade Brasileira de Angiologia e Cirurgia Vascular, Sociedade Brasileira de Infectologia, Sociedade Brasileira de Pneumologia e Tisiologia e Sociedade Brasileira de Reumatologia

48. PATIENTS WITH ESTABLISHED RHEUMATOID ARTHRITIS SHOW IMPAIRED QUADRICEPS MUSCLE MORPHOLOGY ASSESSED BY ULTRASOUND AND MUSCLE STRENGTH IMPAIRED OVER TIME: A COHORT STUDY

49. PRELIMINARY ANALYSIS OF PROTEOMIC IN RHEUMATOID ARTHRITIS AND COVID-19 PATIENTS FROM PERNAMBUCO: REUMACOV BRASIL DATA

50. THE IMPACT OF COVID-19 IN PATIENTS WITH SYSTEMIC VASCULITIDES. DATA FROM REUMACOV BRAZIL REGISTER

Catalog

Books, media, physical & digital resources